PRODUCTS
Launched Products
R&D Vaccine
13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (TT/DT)
Launched in September 2021

view details

13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (TT/DT)
Varicella Vaccine, Freeze-dried
Newly Launched

view details

Varicella Vaccine, Freeze-dried
Hepatitis B Vaccine
Launched in March 2010

view details

Hepatitis B Vaccine
23-Valent Pneumococcal Polysaccharide Vaccine
Launched in August 2019

view details

23-Valent Pneumococcal Polysaccharide Vaccine
DTaP/Hib combied vaccine
Launched in September 2013

view details

DTaP/Hib combied vaccine
Poliomyelitis Vaccine (Vero Cells)，Inactivated，Sabin Strain

view details

Poliomyelitis Vaccine (Vero Cells)，Inactivated，Sabin Strain
ABOUT BIOKANGTAI
Leading innovative biopharmaceutical enterprise
Since its establishment in 1992, BioKangtai has undertaken a number of key scientific research projects and technology development tasks at the national, provincial, and municipal levels. It has processed core technologies such as polyvalent vaccines, genetic engineering vaccines, and other new technology R&D and industrialization core competitiveness.
Development History
+
Years
Production Base
m²
In Vaccine Research
+
Item
Research staff
+
Available vaccine varieties
+

view details

INTERNATIONAL BUSINESS DEVELOPMENT
Business development covers 6 regions and more than 20 countries.

view details

Latin America
Middle East and North Africa
Sub-Saharan Africa
CIS
Southeast Asia
South Asia
全球布局1
Latin America
Middle East and North Africa
Sub-Saharan Africa
CIS
Southeast Asia
South Asia
NEWS CENTER
Provide the latest information
Company Information Industry News

view details

view details

Biominhai Collaborates with Dek Vaccines for 13-Valent PCV Technology Transfer and Drug Supply
Company Information
Biominhai Collaborates with Dek Vaccines for 13-Valent PCV Technology Transfer and Drug Supply
read more >>
Join Us at CPHI China 2025 （#W4G66）
Company Information
Join Us at CPHI China 2025 （#W4G66）
read more >>
BioKangtai Advances Oral Pentavalent Rotavirus Vaccine to Phase III Clinical Trial
Company Information
BioKangtai Advances Oral Pentavalent Rotavirus Vaccine to Phase III Clinical Trial
read more >>
BioKangtai: 20-Valent Pneumococcal Vaccine Enters Phase II Clinical Trial
Company Information
BioKangtai: 20-Valent Pneumococcal Vaccine Enters Phase II Clinical Trial
read more >>
BioKangtai and AstraZeneca Announce Strategic Partnership to Advance Global Vaccine Innovation
Company Information
BioKangtai and AstraZeneca Announce Strategic Partnership to Advance Global Vaccine Innovation
read more >>
BioKangtai at VIF: Shaping the Future of Global Vaccine Cooperation
Company Information
BioKangtai at VIF: Shaping the Future of Global Vaccine Cooperation
read more >>
BioKangtai Reaches Vaccine Technology Transfer Cooperation Intent with Ethiopia
Company Information
BioKangtai Reaches Vaccine Technology Transfer Cooperation Intent with Ethiopia
read more >>
DCVMN CEO Visits BioMinhai: Paving the Way for Vaccine Collaboration
Company Information
DCVMN CEO Visits BioMinhai: Paving the Way for Vaccine Collaboration
read more >>
BioKangtai’ s COVID-19 Inactivated Vaccine Received Approval for Clinical Trial
Company Information
BioKangtai’ s COVID-19 Inactivated Vaccine Received Approval for Clinical Trial
read more >>
Indigenous COVID-19 vaccine put into use in city
Company Information
Indigenous COVID-19 vaccine put into use in city
read more >>
Phase III Clinical Trial of BIOKANGTAI COVID-19 Vaccine Initiated in Malaysia
Company Information
Phase III Clinical Trial of BIOKANGTAI COVID-19 Vaccine Initiated in Malaysia
read more >>
BIOKANGTAI COVID-19 Vaccine Approved for Phase III Clinical Trial in the Philippines
Company Information
BIOKANGTAI COVID-19 Vaccine Approved for Phase III Clinical Trial in the Philippines
read more >>
Shenzhen Kangtai says vaccine effective against Delta variant
Company Information
Shenzhen Kangtai says vaccine effective against Delta variant
read more >>
Recombinant COVID-19 Vaccine (Adenovirus Vector) licensed for manufacturing
Company Information
Recombinant COVID-19 Vaccine (Adenovirus Vector) licensed for manufacturing
read more >>
BioKangtai's Adenovirus Vector COVID-19 Vaccine Obtained EUA in Indonesia
Company Information
BioKangtai's Adenovirus Vector COVID-19 Vaccine Obtained EUA in Indonesia
read more >>
China's BioKangtai Begins First Shipment of AstraZeneca's COVID-19 Shot
Company Information
China's BioKangtai Begins First Shipment of AstraZeneca's COVID-19 Shot
read more >>
Kangtai Adenovirus Vector COVID-19 Vaccine (KCONECAVAC) Exported for the First Time
Company Information
Kangtai Adenovirus Vector COVID-19 Vaccine (KCONECAVAC) Exported for the First Time
read more >>
BioKangtai 30 Million Doses of Adenovirus Vector COVID-19 Vaccine (KCONECAVAC) Exported
Company Information
BioKangtai 30 Million Doses of Adenovirus Vector COVID-19 Vaccine (KCONECAVAC) Exported
read more >>
BioKangtai Adenovirus Vector COVID-19 Vaccine (KCONECAVAC) Was Approved As Booster Dose in Indonesia
Company Information
BioKangtai Adenovirus Vector COVID-19 Vaccine (KCONECAVAC) Was Approved As Booster Dose in Indonesia
read more >>
Licensing and Agency Agreement Signed between Beijing Minhai (Biokangtai) and Phil. Pharmawealth, Inc.
Company Information
Licensing and Agency Agreement Signed between Beijing Minhai (Biokangtai) and Phil. Pharmawealth, Inc.
read more >>
BioKangtai’s Shenzhen Guangming Base has passed the GMP certification in the Philippines
Company Information
BioKangtai’s Shenzhen Guangming Base has passed the GMP certification in the Philippines
read more >>
BioKangtai passed the EU QP audit quality management system and reached the EU GMP standard
Company Information
BioKangtai passed the EU QP audit quality management system and reached the EU GMP standard
read more >>
Shenzhen starts offering Kangtai COVID booster shots
Company Information
Shenzhen starts offering Kangtai COVID booster shots
read more >>
BioKangtai's Inactivated COVID-19 Vaccine (Vero Cell) is Approved Homologous Booster Vaccination in China
Company Information
BioKangtai's Inactivated COVID-19 Vaccine (Vero Cell) is Approved Homologous Booster Vaccination in China
read more >>
National Liver Love Day: Timely vaccination of hepatitisB vaccine…
Company Information
National Liver Love Day: Timely vaccination of hepatitisB vaccine…
read more >>
China, Malaysia companies inks deal on clinical trial, commercialization of COVID-19 vaccines
Industry News
China, Malaysia companies inks deal on clinical trial, commercialization of COVID-19 vaccines
read more >>
COVID-19: A Basic Guide to Different Vaccine Types and How They Work
Industry News
COVID-19: A Basic Guide to Different Vaccine Types and How They Work
read more >>
With global push for COVID-19 vaccines, China aims to win friends and cut deals
Industry News
With global push for COVID-19 vaccines, China aims to win friends and cut deals
read more >>